CCDC162P
|
|
coiled-coil domain containing 162, pseudogene
|
|
21
|
0.890 |
0.154 |
|
0.100 |
None
|
1.000 |
5
|
4
|
2009 |
2018 |
LINC01221
|
|
long intergenic non-protein coding RNA 1221
|
|
10
|
1.000 |
0.038 |
|
0.100 |
None
|
1.000 |
3
|
2
|
2016 |
2018 |
Entrez Id: |
28 |
Gene Symbol: |
ABO |
ABO
|
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
443
|
0.427 |
0.885 |
|
0.100 |
None
|
1.000 |
3
|
4
|
2016 |
2018 |
TMEM72-AS1
|
|
TMEM72 antisense RNA 1
|
|
7
|
|
|
|
0.100 |
None
|
1.000 |
2
|
2
|
2016 |
2018 |
MIR4435-2HG
|
|
MIR4435-2 host gene
|
|
86
|
0.604 |
0.692 |
|
0.100 |
None
|
1.000 |
2
|
5
|
2012 |
2016 |
Entrez Id: |
100129696 |
Gene Symbol: |
INHCAP |
INHCAP
|
|
inhibitor of carbonic anhydrase pseudogene
|
|
17
|
0.890 |
0.231 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
Entrez Id: |
100270847 |
Gene Symbol: |
RPL6P9 |
RPL6P9
|
|
ribosomal protein L6 pseudogene 9
|
|
1
|
|
|
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
STARD4-AS1
|
|
STARD4 antisense RNA 1
|
|
12
|
0.890 |
0.115 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2018 |
2018 |
TSPOAP1-AS1
|
|
TSPOAP1, SUPT4H1 and RNF43 antisense RNA 1
|
|
21
|
0.792 |
0.346 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
RAB11B-AS1
|
|
RAB11B antisense RNA 1
|
|
7
|
0.890 |
0.038 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
NPHP3-ACAD11
|
|
NPHP3-ACAD11 readthrough (NMD candidate)
|
|
82
|
0.663 |
0.577 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
MEF2C-AS1
|
|
MEF2C antisense RNA 1
|
|
23
|
0.861 |
0.154 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
HORMAD2-AS1
|
|
HORMAD2 and MTMR3 antisense RNA 1
|
|
7
|
0.839 |
0.308 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
Entrez Id: |
105373557 |
Gene Symbol: |
SOCAR |
SOCAR
|
|
serous ovarian cancer associated RNA
|
|
15
|
0.821 |
0.231 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
CSRP3-AS1
|
|
CSRP3 and E2F8 antisense RNA 1
|
|
8
|
|
|
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
EHMT2-AS1
|
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
14
|
0.780 |
0.462 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2013 |
2013 |
Entrez Id: |
137196 |
Gene Symbol: |
CCDC26 |
CCDC26
|
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
60
|
0.647 |
0.615 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
PSMA3-AS1
|
|
PSMA3 antisense RNA 1
|
|
7
|
0.931 |
0.154 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
LINC01122
|
|
long intergenic non-protein coding RNA 1122
|
|
24
|
0.821 |
0.269 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
Entrez Id: |
401237 |
Gene Symbol: |
CASC15 |
CASC15
|
|
cancer susceptibility 15
|
|
90
|
0.603 |
0.577 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
SLC22A20P
|
A6NK97
|
solute carrier family 22 member 20, pseudogene
|
|
2
|
|
|
|
0.100 |
None
|
1.000 |
1
|
1
|
2018 |
2018 |
Entrez Id: |
5820 |
Gene Symbol: |
PVT1 |
PVT1
|
|
Pvt1 oncogene
|
|
190
|
0.495 |
0.731 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
LINC01137
|
|
long intergenic non-protein coding RNA 1137
|
|
5
|
|
|
|
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
Entrez Id: |
948 |
Gene Symbol: |
CD36 |
CD36
|
P16671
|
CD36 molecule
|
Receptor
|
351
|
0.446 |
0.846 |
1.1E-60 |
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |
Entrez Id: |
63892 |
Gene Symbol: |
THADA |
THADA
|
Q6YHU6
|
THADA armadillo repeat containing
|
Receptor
|
47
|
0.686 |
0.500 |
4.6E-41 |
0.100 |
None
|
1.000 |
1
|
1
|
2016 |
2016 |